Clinical significance of APVS embolization in the treatment of TACE combined with portal vein stent in patients with MPVTT
10.3760/cma.j.issn.1008-1372.2017.06.020
- VernacularTitle:TACE联合门静脉支架治疗MPVTT时APVS栓塞的应用分析
- Author:
Chenxuan FU
;
Hong WEI
- Keywords:
Chemoembolization,therapeutic;
Stents;
Portal vein/PA/SU;
Arteriovenous fistula/SU
- From:
Journal of Chinese Physician
2017;19(6):872-875
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the efficiency of liver cancer with portal vein tumor thrombus (MPVTT),hepatic artery portal vein fistula (APVS) in patients with hepatic artery chemoembolization (TACE) combined with the clinical value of portal vein stent during treatment with APVS embolization.Methods From January 2012 to October 2014,59 cases of HCC patients who accepted the treatment of TACE + stent in portal vein embolization of + APVS surgery,companied with MPVTT and APVS were ret rospectively analyzed.The liver function,portal vein angiography and pressure at different time points were measured and compared before and after treatment,and follow-up and prognosis were recorded.Results After treatment with albumin,platelets (PLT) levels were higher than those before treatment (P ＜ 0.05),with PT values lower than before treatment (P ＜ 0.05).No statistical significance was found for aspartate aminotransferase (AST),alanine aminotransferase (ALT) before and after treatment (P ＞ 0.05).Stent implantation before and after stent implantation,the portal venous pressure of APVS embolization had signif icant difference (P ＜ 0.05).Portal venous pressure level of stent implantation was lower than before stent implantation (P ＜ 0.05).The portal venous pressure level of APVS embolization was lower than the stent implantation before and after stent implantation (P ＜ 0.05).At the 12 months after treatment,28 cases survived (47.46％);24 months after treatment,11 cases survived (18.64％) of the group;a total of 3 patients was lost to follow-up,the median survival time of the patients 24 months 16.5 months.Conclusions Liver cancer with MPVTT and APVS in the TACE combined with portal vein stent in the treatment process using APVS embolization can further improve the portal vein blood flow,and reduce the pressure of Dortal vein.
